Advertisement

Archives of Virology

, Volume 160, Issue 2, pp 441–445 | Cite as

Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma

  • Lu Han
  • Lingling Sun
  • Zhenzhen Zhao
  • Yan Chao
  • Zhifu Sun
  • Hui Li
  • Bing LuoEmail author
Brief Report

Abstract

To characterize the sequence variation and the potential implication of the Epstein-Barr virus (EBV) oncogene in lymphoma, BamHI-C fragment rightward reading frame 1 (BCRF1) was sequenced in different types of EBV-positive lymphoma in northern China, and polymorphisms were compared with previous variation data from other malignancies. The dominate subtype of BCRF1 in EBV-positive lymphoma was the B95-8 prototype, and a mutation in the signal peptide was more strongly associated with Hodgkin’s lymphoma. The high conservation of BCRF1 in EBV-positive lymphoma suggests its important role in maintaining the basic biological activity and immunosuppressive functions of the virus.

Keywords

Lymphoma Mature Protein Signal Peptide Region Lytic Phase Throat Wash 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Grant sponsor: Specialized Research Fund for the Doctoral Program of Higher Education; Grant number: 20133706110001; Grant sponsor: Natural Science Foundation of Shandong Province; Grant number: ZR2011CM016. Grant sponsor: Science and Technology of Qingdao City, China; Grant number: 13-1-3-50-jch.

References

  1. 1.
    Bornkamm GW (2009) Epstein-Barr virus and the pathogenesis of Burkitt’s lymphoma: more questions than answers. Int J Cancer 124(8):1745–1755. doi: 10.1002/ijc.24223 PubMedCrossRefGoogle Scholar
  2. 2.
    Li DJ, Bei JX, Mai SJ, Xu JF, Chen LZ, Zhang RH, Yu XJ, Hong MH, Zeng YX, Kang T (2009) The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma. J Med Virol 81(7):1253–1260. doi: 10.1002/jmv.21503 PubMedCrossRefGoogle Scholar
  3. 3.
    Niedobitek G (2000) Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 53(5):248–254PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Thompson MP, Kurzrock R (2004) Epstein-Barr virus and cancer. Clin Cancer Res 10(3):803–821PubMedCrossRefGoogle Scholar
  5. 5.
    Uozaki H, Fukayama M (2008) Epstein-Barr virus and gastric carcinoma–viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1(3):198–216PubMedCentralPubMedGoogle Scholar
  6. 6.
    Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ (2003) Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45(1):1–36PubMedCrossRefGoogle Scholar
  7. 7.
    Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248(4960):1230–1234PubMedCrossRefGoogle Scholar
  8. 8.
    Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88(4):1172–1176PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Stewart JP, Behm FG, Arrand JR, Rooney CM (1994) Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200(2):724–732. doi: 10.1006/viro.1994.1236 PubMedCrossRefGoogle Scholar
  10. 10.
    Touitou R, Cochet C, Joab I (1996) Transcriptional analysis of the Epstein-Barr virus interleukin-10 homologue during the lytic cycle. J Gen Virol 77(Pt 6):1163–1168PubMedCrossRefGoogle Scholar
  11. 11.
    Sairenji T, Ohnishi E, Inouye S, Kurata T (1998) Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines. Viral Immunol 11(4):221–231PubMedCrossRefGoogle Scholar
  12. 12.
    Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250(4982):830–832PubMedCrossRefGoogle Scholar
  13. 13.
    Kurilla MG, Swaminathan S, Welsh RM, Kieff E, Brutkiewicz RR (1993) Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J Virol 67(12):7623–7628PubMedCentralPubMedGoogle Scholar
  14. 14.
    Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B (2011) Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol 83(4):644–650. doi: 10.1002/jmv.22091 PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang XS, Song KH, Mai HQ, Jia WH, Feng BJ, Xia JC, Zhang RH, Huang LX, Yu XJ, Feng QS, Huang P, Chen JJ, Zeng YX (2002) The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett 176(1):65–73PubMedCrossRefGoogle Scholar
  16. 16.
    Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K (2009) The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 143(2):209–221. doi: 10.1016/j.virusres.2009.07.005 PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Chen JN, Ding YG, Feng ZY, Li HG, He D, Du H, Wu B, Shao CK (2010) Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J Med Virol 82(4):658–667. doi: 10.1002/jmv.21731 PubMedCrossRefGoogle Scholar
  18. 18.
    Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T (1996) Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74(4):625–631PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Perlman D, Halvorson HO (1983) A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides. J Mol Biol 167(2):391–409PubMedCrossRefGoogle Scholar
  20. 20.
    von Heijne G (1983) Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 133(1):17–21CrossRefGoogle Scholar
  21. 21.
    Zdanov A, Schalk-Hihi C, Menon S, Moore KW, Wlodawer A (1997) Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10. J Mol Biol 268(2):460–467. doi: 10.1006/jmbi.1997.0990 PubMedCrossRefGoogle Scholar
  22. 22.
    Yoon SI, Jones BC, Logsdon NJ, Walter MR (2005) Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain. Structure 13(4):551–564. doi: 10.1016/j.str.2005.01.016 PubMedCrossRefGoogle Scholar
  23. 23.
    Yea C, Tellier R, Chong P, Westmacott G, Marrie RA, Bar-Or A, Banwell B (2013) Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology 81(16):1392–1399. doi: 10.1212/WNL.0b013e3182a841e4 PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Gesser B, Leffers H, Jinquan T, Vestergaard C, Kirstein N, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG (1997) Identification of functional domains on human interleukin 10. Proc Natl Acad Sci USA 94(26):14620–14625PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Ding Y, Qin L, Kotenko SV, Pestka S, Bromberg JS (2000) A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med 191(2):213–224PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Karaplis AC, Lim SK, Baba H, Arnold A, Kronenberg HM (1995) Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 270(4):1629–1635PubMedCrossRefGoogle Scholar
  27. 27.
    Whittington HA, Freeburn RW, Godinho SI, Egan J, Haider Y, Millar AB (2003) Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes Immun 4(4):258–264. doi: 10.1038/sj.gene.6363959 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2014

Authors and Affiliations

  • Lu Han
    • 1
  • Lingling Sun
    • 2
  • Zhenzhen Zhao
    • 1
  • Yan Chao
    • 3
  • Zhifu Sun
    • 4
  • Hui Li
    • 5
  • Bing Luo
    • 1
    Email author
  1. 1.Department of Medical MicrobiologyQingdao University Medical CollegeQingdaoChina
  2. 2.Department of PathologyAffiliated Hospital of Qingdao University Medical CollegeQingdaoChina
  3. 3.Department of Blood TransfusionThe Second Affiliated Hospital of Guangzhou University of Chinese MedicineGuangzhouChina
  4. 4.Department of Health Sciences ResearchMayo ClinicRochesterUSA
  5. 5.Department of Clinical LaboratoryThe Affiliated Hospital of Qingdao University Medical CollegeQingdaoChina

Personalised recommendations